MetaStat Labs Gets State Licensures

Dec 19, 2016

|

NEW YORK (360Dx) – MetaStat announced today that it has received California, Florida, Pennsylvania, and Rhode Island licensure for its Boston-based digital pathology laboratory.

The company, which received CLIA certification from the Centers for Medicare and Medicaid Services last year, said it can now accept clinical samples from 48 states.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

MetaStat Labs Gets State Licensures

To read the full story....

Breaking News

Spectrum Solutions, UCLA Partner to Study Saliva-Based Early-Stage Lung Cancer Detection

T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates

Abbott Q4 Diagnostics Revenues Up 111 Percent, FY20 Revenues Up 9 Percent

Siemens Healthineers Q1 Diagnostics Revenues Rise 17 Percent on Pandemic-Related Demand

Abbott Panbio SARS-CoV-2 Rapid Antigen Test Nabs CE Mark for Asymptomatic Screening, Self-Collection

Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

Featured White Papers

Trends in Variant Interpretation Workflows: Expert Insights to Advance NGS Oncology Profiling

What's Popular?

NeoGenomics to Grow Pharma, Informatics Divisions Through CDx Agreements, Acquisitions

Spectrum Solutions, UCLA Partner to Study Saliva-Based Early-Stage Lung Cancer Detection

Todos Medical Obtains $3.4M Investment From Yozma Group Korea

Caris Shares Data for AI-Driven Tumor Origin Prediction, Hinting at Diagnostic, Patient Benefit

OncoLab Diagnostics Targets Cancer Recurrence Monitoring with CTC-Derived Biomarker Assay

Sponsorships